Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Management Reorg Brings In Shaw To Oversee Bio-Medicines

Executive Summary

Shaw is the former US President of rival Novartis and a rising figure in big pharma. She will take over the role previously held by Ricks, who became CEO Jan. 1. Conterno will assume President USA role.

Advertisement

Related Content

The Outcomes-Based Reimbursement Experiment
Glass Ceiling Cracked; Pharma Forges Path To Gender Equality By 2040?
Lilly BioMedicines Head Ricks Tasked With Overseeing Growth Phase As Next CEO
Lilly’s Psoriasis Drug Taltz Set For Second Quarter Launch
Novartis On Payer Contracts, Other Updates From BIO CEO & Investor Conference

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel